Employee Benefits
Specialty Rx
White Paper
Since the 1990s, the number of specialty drugs available on the market has increased exponentially. Employer-sponsored health plans have seen a rise in pharmacy expense due to the increasing availability and costs of these medications. As a result, employers are seeking ways to curb specialty Rx spend.
Download this white paper to learn:
- Approaches to reducing spending
- Compliance and regulatory consequences of those approaches
- Possible solutions and considerations
Related Insights
Professional Services+ Collaborative
Assess Export Compliance Risk During the M&A Process
October 9, 2024
Read More
Professional Services+ Collaborative
Understanding the Impact of NIST CSF 2.0: Key Updates and Their Significance
October 3, 2024
Read More
Business Insurance
Insurance Considerations for Riots, Vandalism and Civil Unrest
October 1, 2024
Read More